UBS has added one of the world's largest oilfield services companies to its Dividend Ruler portfolio. Top dividend stocks continue to be outstanding holdings in long-term growth and income portfolios.
Cowen sees the potential for super-mergers in biotech, as well as a large group of smaller targets that may be in the sights of bigger companies now.
The Deutsche Bank take is very smart. It is prudent now to buy energy stocks viewed as either undervalued or having incredible long-term prospects.
Merrill Lynch has added two new stocks to its Endeavor portfolio, which has the Russell 2000 so far this year.
A new report from Credit Suisse points to three master limited partnership stocks the firm feels are the most undervalued after everything is said and done.
With earnings and price targets getting moved higher via revisions, and quarterly earnings reports are already in the can, these stocks make good sense for aggressive growth accounts.
The Jefferies team points out that Netflix has overtaken traditional TV in term of viewership. The times are changing, and the content providers are a good spot for growth investors.
A new research report from Savita Subramanian and her well-regarded team at Merrill Lynch points out that some of the biggest positive surprises have been from the mega-cap stocks.
Credit Suisse expects that biotech stocks will see the most promotions in the coming rebalance of the Russell Indexes.
After RBC's firm's Mobile & Cloud investors day, the firm raised price targets on three top stocks it has rated Outperform.
A new research report from Jefferies highlights top growth stock calls for this week. These four have solid upside potential and good long-term growth prospects.
These tech stocks trade below the overall market multiple, pay solid dividends and are rated Outperform at Oppenheimer.
Insiders havereappeared after being mostly in hibernation as first-quarter earnings results were reported by many of the major corporations in the United States over the past five weeks.
The windows for insiders to buy and sell stock sure look like they came flying open this week, as insiders at top companies dipped into their wallets and started buying stock big time.
A new Merrill Lynch report cites some of the incredible changes in technology that are occurring literally right now.
In a new report, the RBC team focused on the companies that are making the most progress with treatments for patients with breast cancer.
Some of the top technology companies that are presenting at the Jefferies Technology Media and Telecom conference are also on the Jefferies Franchise Picks list.
A new Jefferies report includes a list of stocks that stand to benefit from the recent upswing in FTTP deployment.
With oil bursting through the $60 level, some people are starting to get bullish again. UBS says that the big three in land drilling are where the best odds lie right now.
A new research note from SunTrust Robinson Humphrey mentions four stocks that they think could possibly get swept up in the biotech M&A excitement.